Neurogenic bowel dysfunction score in spinal cord-injured patients : translation and validation of the Dutch-language NBD score
© 2021. The Author(s), under exclusive licence to International Spinal Cord Society..
STUDY DESIGN: This is a prospective validation study.
OBJECTIVES: The neurogenic bowel dysfunction (NBD) score is a widely used symptom-based questionnaire evaluating bowel dysfunction and its impact on quality of life (QoL) in spinal cord-injured patients. This study aimed to translate and validate a Dutch-language NBD score in patients with SCI.
SETTING: Patients with SCI visiting the urology department or general practitioner (GP) in Rotterdam, the Netherlands.
METHODS: Standardized guidelines were followed for the translation and validation process of the NBD score. Adult patients with SCI visiting our urology department were asked to participate by filling in a set of questionnaires: the NBD score, the Fecal Incontinence Quality of Life scale (FIQL), the Fecal Incontinence Severity Index (FISI), and the European Quality of life 5-Dimension 3-Level questionnaire (EQ-5D-3L) at baseline and 1-2 weeks afterward. A control group recruited at a GP office completed the questionnaires once. The following measurement properties were evaluated: content validity, internal consistency, reproducibility, criterion-, and construct validity.
RESULTS: Fifty-eight patients and 50 references were included. Content validity was adequate, internal consistency was moderate (Cronbach's alpha 0.56 and 0.30) and reproducibility was adequate (ICC 0.87). Criterion validity was confirmed; NBD score correlated significantly with the FIQL, FISI, and EQ-5D-3L. NBD scores in the patient group were significantly higher than in references, demonstrating good construct validity.
CONCLUSIONS: The Dutch-language version of the NBD score showed moderate to good measurement properties, and therefore is a reliable tool to measure bowel dysfunction in patients with SCI. We recommend standardized usage of this questionnaire for clinical evaluation and research purposes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Spinal cord - 60(2022), 3 vom: 04. März, Seite 223-227 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
van Doorn, Tess [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 24.03.2022 Date Revised 24.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41393-021-00668-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM328936227 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM328936227 | ||
| 003 | DE-627 | ||
| 005 | 20231225204020.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41393-021-00668-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1096.xml |
| 035 | |a (DE-627)NLM328936227 | ||
| 035 | |a (NLM)34349233 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a van Doorn, Tess |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neurogenic bowel dysfunction score in spinal cord-injured patients |b translation and validation of the Dutch-language NBD score |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.03.2022 | ||
| 500 | |a Date Revised 24.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s), under exclusive licence to International Spinal Cord Society. | ||
| 520 | |a STUDY DESIGN: This is a prospective validation study | ||
| 520 | |a OBJECTIVES: The neurogenic bowel dysfunction (NBD) score is a widely used symptom-based questionnaire evaluating bowel dysfunction and its impact on quality of life (QoL) in spinal cord-injured patients. This study aimed to translate and validate a Dutch-language NBD score in patients with SCI | ||
| 520 | |a SETTING: Patients with SCI visiting the urology department or general practitioner (GP) in Rotterdam, the Netherlands | ||
| 520 | |a METHODS: Standardized guidelines were followed for the translation and validation process of the NBD score. Adult patients with SCI visiting our urology department were asked to participate by filling in a set of questionnaires: the NBD score, the Fecal Incontinence Quality of Life scale (FIQL), the Fecal Incontinence Severity Index (FISI), and the European Quality of life 5-Dimension 3-Level questionnaire (EQ-5D-3L) at baseline and 1-2 weeks afterward. A control group recruited at a GP office completed the questionnaires once. The following measurement properties were evaluated: content validity, internal consistency, reproducibility, criterion-, and construct validity | ||
| 520 | |a RESULTS: Fifty-eight patients and 50 references were included. Content validity was adequate, internal consistency was moderate (Cronbach's alpha 0.56 and 0.30) and reproducibility was adequate (ICC 0.87). Criterion validity was confirmed; NBD score correlated significantly with the FIQL, FISI, and EQ-5D-3L. NBD scores in the patient group were significantly higher than in references, demonstrating good construct validity | ||
| 520 | |a CONCLUSIONS: The Dutch-language version of the NBD score showed moderate to good measurement properties, and therefore is a reliable tool to measure bowel dysfunction in patients with SCI. We recommend standardized usage of this questionnaire for clinical evaluation and research purposes | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Groenendijk, Ilse M |e verfasserin |4 aut | |
| 700 | 1 | |a Scheepe, Jeroen R |e verfasserin |4 aut | |
| 700 | 1 | |a Blok, Bertil F M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Spinal cord |d 1998 |g 60(2022), 3 vom: 04. März, Seite 223-227 |w (DE-627)NLM088257398 |x 1476-5624 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2022 |g number:3 |g day:04 |g month:03 |g pages:223-227 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41393-021-00668-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2022 |e 3 |b 04 |c 03 |h 223-227 | ||